Objective The pathophysiology of major depressive disorder (MDD) is still not well
understood. Conflicting results for surrogate biomarkers in MDD have been reported, which …

Objective We attempted to investigate whether dehydroepiandrosterone sulfate (DHEA‐S)
levels are associated with remission of major depressive disorder by assessing scores on …

Background Previous evidence has shown that adrenal androgens,
dehydroepiandrosterone (DHEA) and its sulfate derivative (DHEAS) have significant …

OBJECTIVES: The adrenal androgen dehydroepiandrosterone-sulfate (DHEA-S) seems to
be involved in the pathophysiology of depression, although its precise role in the etiology …

Depression is one of the major causes of disability worldwide, but the complete etiology of
depression is not fully understood. Dehydroepiandrosterone (DHEA) and its sulphated form …

Background Dehydroepiandrosterone (DHEA) and its sulfated ester DHEA-sulfate (DHEA-
S),(together DHEA [S]), are the most abundant adrenal steroids in humans and are found in …

Background Major depressive disorder (MDD) has been associated with low
dehydroepiandrosterone-sulphate (DHEAS),–particularly relative to high cortisol–although …

Objective Dehydroepiandrosterone sulfate (DHEAS) appears to have a protective effect
against depression, but evidence from prospective cohort studies is sparse. Therefore, we …

Background Hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depression
(MDD) have been consistently reported in psychiatry and extend to several neurosteroids …

OBJECTIVE: Clinical studies of endogenous concentrations of dehydroepiandrosterone
(DHEA) and its relation to depression are limited. This study examined whether pre-and post …